A detailed history of Saba Capital Management, L.P. transactions in Grifols Sa stock. As of the latest transaction made, Saba Capital Management, L.P. holds 269,686 shares of GRFS stock, worth $2.52 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
269,686
Holding current value
$2.52 Million
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$6.49 - $9.09 $1.75 Million - $2.45 Million
269,686 New
269,686 $2.44 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.34B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Saba Capital Management, L.P. Portfolio

Follow Saba Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saba Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Saba Capital Management, L.P. with notifications on news.